Fairmount Funds Management as of June 30, 2020
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 14 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals (ACAD) | 12.7 | $28M | 586k | 48.47 | |
| Insmed Com Par $.01 (INSM) | 12.4 | $28M | 1.0M | 27.54 | |
| Zogenix Com New | 11.7 | $26M | 972k | 27.01 | |
| Amicus Therapeutics (FOLD) | 10.1 | $23M | 1.5M | 15.08 | |
| Axsome Therapeutics (AXSM) | 7.9 | $18M | 216k | 82.28 | |
| Iovance Biotherapeutics (IOVA) | 7.4 | $17M | 604k | 27.45 | |
| Allakos (ALLK) | 5.7 | $13M | 179k | 71.86 | |
| Neoleukin Therapeutics | 5.7 | $13M | 770k | 16.60 | |
| Karyopharm Therapeutics (KPTI) | 5.5 | $12M | 652k | 18.94 | |
| Trillium Therapeutics Com New | 5.4 | $12M | 1.5M | 8.09 | |
| Argenx Se Sponsored Adr (ARGX) | 5.1 | $11M | 51k | 225.23 | |
| Amarin Corp Spons Adr New (AMRN) | 4.3 | $9.7M | 1.4M | 6.92 | |
| Enanta Pharmaceuticals (ENTA) | 3.8 | $8.5M | 170k | 50.21 | |
| Kiniksa Pharmaceuticals Com Cl A | 2.3 | $5.1M | 200k | 25.48 |
